SXTC (China SXT Pharmaceuticals) Cash-to-Debt : N/A (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. China SXT Pharmaceuticals's cash to debt ratio for the quarter that ended in Sep. 2024 was N/A.

The historical rank and industry rank for China SXT Pharmaceuticals's Cash-to-Debt or its related term are showing as below:

SXTC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.22 Med: 3.06 Max: 310.07
Current: 4.56

During the past 8 years, China SXT Pharmaceuticals's highest Cash to Debt Ratio was 310.07. The lowest was 0.22. And the median was 3.06.

SXTC's Cash-to-Debt is ranked better than
68.48% of 1012 companies
in the Drug Manufacturers industry
Industry Median: 1.02 vs SXTC: 4.56

China SXT Pharmaceuticals Cash-to-Debt Historical Data

The historical data trend for China SXT Pharmaceuticals's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

China SXT Pharmaceuticals Cash-to-Debt Chart

China SXT Pharmaceuticals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash-to-Debt

Get a 7-Day Free Trial

1.08

310.07

7.59

4.62

4.56

China SXT Pharmaceuticals Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Cash-to-Debt	Get a 7-Day Free Trial											2.47	4.62	3.64	4.56	N/A

Competitive Comparison of China SXT Pharmaceuticals's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, China SXT Pharmaceuticals's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China SXT Pharmaceuticals's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China SXT Pharmaceuticals's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where China SXT Pharmaceuticals's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

China SXT Pharmaceuticals Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

China SXT Pharmaceuticals's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	12.07	/	(2.353	+	0.295)
	=	4.56

China SXT Pharmaceuticals's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

China SXT Pharmaceuticals (NAS:SXTC) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

China SXT Pharmaceuticals Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

China SXT Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

2RY:Germany

Address

No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300

Website

http://www.sxtchina.com

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.